Michigan Senate Bill SB0914

Michigan 2025-2026 Regular Session

• Introduced: 4/22/26
• Refer: 4/22/26

Caption

Insurance: health benefits; application of amount paid by the insured or other certain parties when calculating the insured’s co-pay for a prescription drug; require under certain conditions. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406nn.

Impact

The bill particularly affects both standard health insurance policies and high deductible health plans. For the latter, it stipulates that such plans must still consider payments made towards prescription drugs in their calculations unless doing so would affect the enrollee's eligibility for a health savings account (HSA). This is significant as HSAs are tied to tax benefits and financial planning for healthcare expenses. Any changes in this area could lead to increased clarity and assistance for consumers navigating their insurance options. The law is set to apply to policies issued, renewed, or delivered in Michigan after December 31, 2025, providing time for stakeholders to adjust accordingly.

Summary

Senate Bill 914 (SB0914) proposes amendments to the insurance code of Michigan to address how certain payments are calculated when determining a policyholder's cost-sharing requirements for prescription drugs. Specifically, the bill mandates that health insurance policies that provide coverage for prescription drugs must account for any payments made by the enrollee or on behalf of the enrollee when calculating their overall contributions to out-of-pocket maximums or other cost-sharing requirements. This inclusion seeks to alleviate some financial burdens for insured individuals by ensuring that all payments contribute toward their financial limits under insurance plans.

Contention

Possible points of contention regarding SB0914 might arise from the implications it has on insurance providers and their ability to manage cost-sharing arrangements. Some industry stakeholders may argue that the requirements could increase administrative burdens and lead to higher premiums for consumers, as insurers will need to recalibrate their accounting for these payments. On the other hand, advocates for consumers will likely support the bill, arguing it enhances financial protection for enrollees, particularly those who have significant medical expenses associated with prescription drugs.

Additional_notes

Overall, SB0914 is an important legislative step towards modifying health insurance standards in Michigan, focused on providing clearer guidelines for the treatment of prescription drug payments in relation to overall cost obligations for consumers. As the bill progresses, it will be critical to monitor feedback from insurance entities and the public to understand its full implications.